Blend Labs, Inc. (NYSE:BLND - Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 7,830,000 shares, a decline of 16.0% from the April 30th total of 9,320,000 shares. Based on an average daily volume of 3,430,000 shares, the short-interest ratio is currently 2.3 days. Currently, 3.9% of the shares of the company are sold short.
Wall Street Analysts Forecast Growth
Several equities research analysts recently issued reports on BLND shares. JMP Securities restated a "market outperform" rating and issued a $7.00 target price on shares of Blend Labs in a report on Wednesday, May 28th. Canaccord Genuity Group reiterated a "buy" rating and set a $5.25 price objective on shares of Blend Labs in a research report on Monday, May 12th. Keefe, Bruyette & Woods increased their target price on Blend Labs from $3.50 to $4.00 and gave the company a "market perform" rating in a report on Monday, May 19th. UBS Group cut their price target on Blend Labs from $4.00 to $3.50 and set a "neutral" rating for the company in a research note on Friday, February 28th. Finally, The Goldman Sachs Group lowered their price objective on shares of Blend Labs from $5.60 to $4.80 and set a "buy" rating on the stock in a research note on Monday, May 12th. Two equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $4.90.
Get Our Latest Analysis on BLND
Blend Labs Price Performance
Shares of BLND stock traded up $0.02 during trading hours on Thursday, reaching $3.72. 1,323,310 shares of the company traded hands, compared to its average volume of 3,147,062. Blend Labs has a 12-month low of $2.08 and a 12-month high of $5.53. The company has a market cap of $964.64 million, a P/E ratio of -10.93 and a beta of 1.30. The firm has a 50-day moving average price of $3.38 and a 200 day moving average price of $3.83.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of BLND. Revolve Wealth Partners LLC purchased a new stake in Blend Labs in the 4th quarter worth $132,000. Caprock Group LLC grew its position in shares of Blend Labs by 142.5% during the fourth quarter. Caprock Group LLC now owns 75,032 shares of the company's stock worth $316,000 after purchasing an additional 44,096 shares in the last quarter. Calamos Advisors LLC raised its stake in Blend Labs by 3.6% during the 4th quarter. Calamos Advisors LLC now owns 299,995 shares of the company's stock valued at $1,263,000 after purchasing an additional 10,366 shares during the period. Summit Trail Advisors LLC raised its stake in Blend Labs by 38.1% during the 4th quarter. Summit Trail Advisors LLC now owns 17,947 shares of the company's stock valued at $76,000 after purchasing an additional 4,953 shares during the period. Finally, Quadrant Private Wealth Management LLC purchased a new position in Blend Labs in the 4th quarter worth approximately $320,000. Hedge funds and other institutional investors own 52.56% of the company's stock.
Blend Labs Company Profile
(
Get Free Report)
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Featured Articles
Before you consider Blend Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.
While Blend Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.